期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

甲状腺疾病治疗新观点 被引量：5

原文传递
导出
摘要 甲状腺疾病是一组异质性疾病，包括了甲状腺功能异常和形态改变。功能异常导致甲状腺功能亢进症（甲亢）和减退症（甲减），形态改变表现为甲状腺肿大、结节和癌变。甲状腺疾病患病率之高、近年发病率增长之迅猛以及带来的严重后果已经受到国内外多学科，包括内分泌科、甲状腺外科、核医学科、围产医学、妇产科、儿科等的广泛重视。在各种疾病新的治疗理念和手段层出不穷的今天，甲状腺疾病治疗领域在近几年也有了令人瞩目的进展，以下几方面尤其值得关注。
作者 单忠艳 滕卫平
机构地区 中国医科大学附属第一医院内分泌科
出处 《中华医学杂志》 CAS CSCD 北大核心 2012年第12期795-797,共3页 National Medical Journal of China
关键词 甲状腺疾病 治疗 甲状腺功能异常 甲状腺功能亢进症 形态改变 异质性疾病 甲状腺肿大 甲状腺外科
分类号 R581 [医药卫生—内分泌]
  • 相关文献

参考文献17

  • 1Ladenson PW. Thyroid hormone analogues:ready for prime time[J].Thyroid:Official Journal of the American Thyroid Association,2011.101-102.
  • 2Ladenson PW,Kristensen JD,Ridegway EC. Use of the thyroid hormone analogue eprotirme in satin-treated dyslipidemia[J].New England Journal of Medicine,2010.906-916.
  • 3Chiellini G,Assadi-Porter FM,Haviland J. Effects of chronic 3-iodothyronamine administration on lipid metabolism in rodents.35th Annual Meeting of the European Thyroid Association.Cracow,Poland,2011[J].Eur Thyroid J,2011.75.
  • 4EI Fassi D,Nielsen CH,Bonnema SJ. B lymphocyte deletion with monoclonal antibody rituximab in Graves' disease:a controlled study[J].Journal of Clinical Endocrinology and Metabolism,2007.1769-1772.
  • 5Heemstra KA,Toes RE,Sepers J. Rituximab in relapsing Graves' disease,a phase Ⅰ study[J].Eur J Endocrionl,2008.609-615.
  • 6Hegedus L,Smith TJ,Douglas RS. Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy.Focus on B cell depletion with rituximab[J].Clinical Endocrinology(Oxford),2011.1-8.
  • 7Toulis KA,Anastasillakis AD,Tzellos TG. Selenium supplementation in the treatment of Hashimoto's thyroiditis:a systematic review and a meta-analysis[J].Thyroid:Official Journal of the American Thyroid Association,2010.1163-1173.
  • 8Duntas LH. Selenum and the thyroid:a close-knit connection[J].Journal of Clinical Endocrinology and Metabolism,2010.5180-5188.
  • 9Marcocci C,Kahaly G J,Krassas GE. Selenium and the course of mild Graves' orbitopathy[J].New England Journal of Medicine,2011.1920-1931.
  • 10Xue H,Wang W,Li Y. Selenium upregulates CD4+ CD25 + regulatory T cells in iodine-induced autoimmune thyroiditis model of NOD.H-2h4 mice[J].Endocrine Journal,2010.595-601.

二级参考文献13

  • 1李玉姝 单忠艳 滕卫平 等.甲状腺自身抗体TPOAb和TGAb正常值的研究意义[J].中华检验杂志,2006,29:780-783.
  • 2Morreale de Escobar G,Obregon MJ,Escobar del Rey F.Role of thyroid hormone during early brain development.Eur J Endocrinol,2004,151 (Suppl 3):U25-U37.
  • 3Gyamfi C,Wapner RJ,D' Alton ME.Thyroid dysfunction in pregnancy:the basic science and clinical evidence surrounding the controversy in management.Obstet Gynecol,2009,113:702-707.
  • 4Abalovich M,Amino N,Barbour LA,et al.Management of thyroid dysfunction during pregnancy and postpartum:An Endocrine Society Clinical Practice Guideline.J Clin Endocrinol Metab,2007,92:S1-S47.
  • 5Baloch Z,Carayon P,Conte-Devolx B,et al.Laboratory medicine practice guidelines:laboratory support for the diagnosis and monitoring of thyroid disease.Thyroid,2003,13:3-126.
  • 6Haddow JE,Palomaki GE,Allan WC,et al.Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child.N Engl J Med,1999,341:549-555.
  • 7Klein RZ,Mitchell ML.Maternal hypothyroidism and cognitive development of the offspring.Curr Opin Pediatr,2002,14:443-446.
  • 8Surks MI,Ortiz E,Daniels GH,et al.Subclinical thyroid disease:scientific review and guidelines for diagnosis and management.JAMA,2004,291:228-238.
  • 9de Escobar GM,Ares S,Berbel P,et al.The changing role of maternal thyroid hormone in fetal brain development.Semin Perinatol,2008,32:380-386.
  • 10Pop VJ,de Vries E,van Baar AL,et al.Maternal thyroid peroxidase antibodies during pregnancy:a marker of impaired child development? J Clin Endocrinol Metab,1995,80:3561-3566.

共引文献125

同被引文献47

  • 1唐俊军,吴元佐.正常成人甲状腺的CT研究及临床意义[J].中国医学影像技术,2004,20(z2):4-5. 被引量：8
  • 2王东红.8886名煤矿职工体检中高血脂分析[J].疾病监测与控制,2011,5(3):173-174. 被引量：2
  • 3方向葵.我校教职工2003年体检结果分析[J].中国校医,2004,18(5):440-441. 被引量：9
  • 4朱煜,唐汇敏,邓江平,孙艳华.原发性高尿酸血症患病率调查[J].东南大学学报（医学版）,2007,26(1):41-42. 被引量：15
  • 5宋晋秋.过量摄入碘有可能导致甲状腺疾病发病率升高[J].中华医学杂志,2007,87(20):1440-1440. 被引量：3
  • 6Bossowski A, Stasiak-Barmuta A, Urban M, et al. Analysis of costimulatory molecules 0X40/4-1BB (CD134/CD137) detection on chosen mononuclear ceils in children and adolescents with Graves' disease during methimazole therapy. J Pediatr Endocrinol Metab, 2005, 18: 1365-1372.
  • 7Ye F, Hou P, Wu X, et al. The significance of immune-related molecule expression profiles in an animal model of Graves' disease. Autoimmunity, 2012, 45: 143-152.
  • 8Zhou ZH, Shi Q, Wang JF, et al. Sensitization of multiple myeloma and B lymphoma lines to dexamethasone and gamma- radiation-induced apoptosis by CD40 activation. Apoptosis, 2005, 10 : 123-134.
  • 9Wang F, Yan T, Chen L, et al. Involvement of inducible costimulator ligand (ICOSL) expression in thyroid tissue in hyperthyroidism of Graves' disease patients. J Clin Immunol, 2012, 32: 1253-1262.
  • 10Salmaso C, Olive D, Pesce G, et al. Costimulatory molecules and autoimmune thyroid diseases. Autoimmunity, 2002, 35: 159- 167.

引证文献5

二级引证文献16

中华医学杂志
2012年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部